UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SPCX
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.94% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PROF
6376
Profound Medical
PROF
$215M
| $367K | ﹤0.01% |
55,224
-25,884
| -32% | -$174K |
|
|
EMPG
6377
DELISTED
Empro Group
EMPG
| $367K | ﹤0.01% |
21,136
| – | – |
|
6378
PUT
Harley-Davidson
HOG
$2.76B
| $367K | ﹤0.01% |
15,000
| – | – |
|
6379
Putnam BDC Income ETF
PBDC
$306M
| $366K | ﹤0.01% |
13,454
+168
| +1% | +$4.6K |
|
6380
Lyell Immunopharma
LYEL
$265M
| $365K | ﹤0.01% |
25,982
-5,832
| -18% | -$106K |
|
6381
Knightscope
KSCP
$27.4M
| $362K | ﹤0.01% |
171,737
+60,059
| +54% | +$170K |
|
6382
T. Rowe Price US High Yield ETF
THYF
$840M
| $362K | ﹤0.01% |
7,022
+6,865
| +4,373% | +$355K |
|
6383
Radcom
RDCM
$177M
| $361K | ﹤0.01% |
25,603
+7,214
| +39% | +$101K |
|
|
HGLB
6384
Highland Global Allocation Fund
HGLB
$172M
| $361K | ﹤0.01% |
48,000
-25,732
| -35% | -$206K |
|
6385
PUT
Banco Bradesco
BBD
$36.8B
| $361K | ﹤0.01% |
104,000
| – | – |
|
6386
Immatics
IMTX
$1.34B
| $359K | ﹤0.01% |
35,433
-225,574
| -86% | -$2.38M |
|
|
MPV
6387
Barings Participation Investors
MPV
$184M
| $359K | ﹤0.01% |
21,311
-331
| -2% | -$5.69K |
|
6388
AN2 Therapeutics
ANTX
$185M
| $359K | ﹤0.01% |
74,086
+12,694
| +21% | +$54.6K |
|
6389
CALL
NetApp
NTAP
$38.7B
| $356K | ﹤0.01% |
+2,300
| New | +$301K |
|
|
PLTZ
6390
Defiance Daily Target 2x Short PLTR ETF
PLTZ
$40M
| $355K | ﹤0.01% |
+9,800
| New | +$298K |
|
6391
Global X Hydrogen ETF
HYDR
$108M
| $354K | ﹤0.01% |
+6,675
| New | +$373K |
|
6392
Torrid Holdings
CURV
$231M
| $352K | ﹤0.01% |
188,418
+183,481
| +3,716% | +$321K |
|
|
DGNX
6393
Diginex Ltd
DGNX
$41.1M
| $352K | ﹤0.01% |
237,718
+159,668
| +205% | +$330K |
|
|
IPFX
6394
Inflection Point Acquisition Corp VI
IPFX
$338M
| $351K | ﹤0.01% |
+33,962
| New | +$352K |
|
6395
OneWater Marine
ONEW
$160M
| $351K | ﹤0.01% |
31,147
+2,389
| +8% | +$25.7K |
|
6396
Standard BioTools
LAB
$287M
| $351K | ﹤0.01% |
425,977
+120,855
| +40% | +$114K |
|
6397
Ponce Financial Group
PDLB
$491M
| $350K | ﹤0.01% |
17,551
-1,850
| -10% | -$33.8K |
|
6398
MaxCyte
MXCT
$124M
| $350K | ﹤0.01% |
284,273
+13,219
| +5% | +$13.2K |
|
6399
Invesco Bond Fund
VBF
$164M
| $349K | ﹤0.01% |
23,021
-2,479
| -10% | -$37.2K |
|
6400
CS Disco
LAW
$273M
| $348K | ﹤0.01% |
92,124
-11,463
| -11% | -$44.4K |
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.